» Articles » PMID: 25057428

A Proposal for Six Sigma Integration for Large-Scale Production of Penicillin G and Subsequent Conversion to 6-APA

Overview
Publisher Wiley
Specialty Chemistry
Date 2014 Jul 25
PMID 25057428
Citations 2
Authors
Affiliations
Soon will be listed here.
Abstract

Six Sigma methodology has been successfully applied to daily operations by several leading global private firms including GE and Motorola, to leverage their net profits. Comparatively, limited studies have been conducted to find out whether this highly successful methodology can be applied to research and development (R&D). In the current study, we have reviewed and proposed a process for a probable integration of Six Sigma methodology to large-scale production of Penicillin G and its subsequent conversion to 6-aminopenicillanic acid (6-APA). It is anticipated that the important aspects of quality control and quality assurance will highly benefit from the integration of Six Sigma methodology in mass production of Penicillin G and/or its conversion to 6-APA.

Citing Articles

Isolation and Molecular Characterization of Indigenous / Strain Portfolio for Penicillin V Production.

Sawant A, Navale V, Vamkudoth K Microorganisms. 2023; 11(5).

PMID: 37317105 PMC: 10221864. DOI: 10.3390/microorganisms11051132.


Exploitation of E. coli for the production of penicillin G amidase: a tool for the synthesis of semisynthetic β-lactam antibiotics.

Sambyal K, Singh R J Genet Eng Biotechnol. 2021; 19(1):156.

PMID: 34652570 PMC: 8521562. DOI: 10.1186/s43141-021-00263-7.

References
1.
Scherrer S, Robas N, Zouheiry H, Branlant G, Branlant C . Periplasmic aggregation limits the proteolytic maturation of the Escherichia coli penicillin G amidase precursor polypeptide. Appl Microbiol Biotechnol. 1994; 42(1):85-91. DOI: 10.1007/BF00170229. View

2.
Roingeard P . Viral detection by electron microscopy: past, present and future. Biol Cell. 2008; 100(8):491-501. PMC: 7161876. DOI: 10.1042/BC20070173. View

3.
Mattanovich D, Branduardi P, Dato L, Gasser B, Sauer M, Porro D . Recombinant protein production in yeasts. Methods Mol Biol. 2011; 824:329-58. DOI: 10.1007/978-1-61779-433-9_17. View

4.
Srirangan K, Orr V, Akawi L, Westbrook A, Moo-Young M, Chou C . Biotechnological advances on penicillin G acylase: pharmaceutical implications, unique expression mechanism and production strategies. Biotechnol Adv. 2013; 31(8):1319-32. DOI: 10.1016/j.biotechadv.2013.05.006. View

5.
Westers L, Westers H, Quax W . Bacillus subtilis as cell factory for pharmaceutical proteins: a biotechnological approach to optimize the host organism. Biochim Biophys Acta. 2004; 1694(1-3):299-310. DOI: 10.1016/j.bbamcr.2004.02.011. View